 |
|
HL301 in the treatment of acute bronchitis: a phase 2b, randomized, double-blind, placebocontrolled, multicenter study
Sang Won Yoon, Myung Jae Park, Chin Kook Rhee, Joo Hun Park, Sang Yeub Lee, Do Jin Kim, Dong Gyu Kim, Jae Yeol Kim
Korean J Intern Med. 2020;35(1):133-141. Published online 2019 Apr 9 DOI: https://doi.org/10.3904/kjim.2018.181
|
|
Citations to this article as recorded by
 Efficacy and Safety of YJP-40 in Patients with Acute Bronchitis: A Randomized, Double-Blind, Parallel Group Study
Chin Kook Rhee
Tuberculosis and Respiratory Diseases.2025; 88(3): 583. CrossRef Efficacy and safety of HL-301 compared with erdosteine in acute bronchitis: a randomized, double-blind, non-inferiority trial
Ji-Yong Moon, Joon Young Choi, Youlim Kim, Hye Jung Park, Yong Bum Park, Seong Yong Lim, Kyung Hoon Min, Deog Kyeom Kim, Chin Kook Rhee, Seung Won Ra, Chang Youl Lee, Yong Il Hwang, Kwang Ha Yoo
The Korean Journal of Internal Medicine.2025; 40(5): 790. CrossRef Safety and Efficacy of HL301 In Radiation Pneumonitis in Patients With Unresectable Non-Small Cell Lung Cancer Receiving Curative Concurrent Chemoradiotherapy: A Multicenter, Randomized, Double-Blinded, Placebo-Controlled, Phase 2a Clinical Trial
Kyung Hwan Kim, Nahyun Kang, Si Yeol Song, Hak Jae Kim, Yeon-Sil Kim, Mi Jin Oh, Jaeho Cho
International Journal of Radiation Oncology*Biology*Physics.2024; 120(2): 432. CrossRef COVID-19 and herbal practice: A United Kingdom practitioner survey
Rachael Frost, Sukvinder Kaur Bhamra, Barbara Pendry, Michael Heinrich
Advances in Integrative Medicine.2021; 8(4): 256. CrossRef HL301 versus Umckamin in the treatment of acute bronchitis: a phase III, randomized, controlled, double-blind, multicenter study
Won-Young Kim, Myung Jae Park, Chin Kook Rhee, Sang Yeub Lee, Do Jin Kim, Dong Gyu Kim, Chang-Min Choi, Deog Kyeom Kim, Yee Hyung Kim, Ho Joo Yoon, Jae Yeol Kim
Current Medical Research and Opinion.2020; 36(3): 503. CrossRef
|